Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

bioAffinity Technologies, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 4 GIRGENTI STEVEN (Executive Chairman) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 8,227 shares @ $2.28, valued at $18.8k
Granted 9,920 shares @ $1.89, valued at $18.7k
Granted 10,245 shares @ $1.83, valued at $18.7k
Granted 26,315 shares @ $2.28, valued at $60k
07/06/2023 4 GIRGENTI STEVEN (Executive Chairman) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 8,227 shares @ $2.28, valued at $18.8k
Granted 9,920 shares @ $1.89, valued at $18.7k
Granted 10,245 shares @ $1.83, valued at $18.7k
07/06/2023 4 Rubin Gary D (10% Owner) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 8,227 shares @ $2.28, valued at $18.8k
Granted 9,920 shares @ $1.89, valued at $18.7k
Granted 10,245 shares @ $1.83, valued at $18.7k
07/06/2023 4 Zannes Maria (President, CEO) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 8,227 shares @ $2.28, valued at $18.8k
Granted 9,920 shares @ $1.89, valued at $18.7k
Granted 26,178 shares @ $1.91, valued at $50k
Granted 10,245 shares @ $1.83, valued at $18.7k
07/06/2023 4 KNIGHT PETER S (Director) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 8,227 shares @ $2.28, valued at $18.8k
Granted 9,920 shares @ $1.89, valued at $18.7k
Granted 10,245 shares @ $1.83, valued at $18.7k
07/06/2023 4 Dougherty Michael Philip (CFO) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 52,356 shares @ $1.91, valued at $100k
03/07/2023 4 Perlmutter Nathan M (10% Owner) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Converted 31,780 shares @ $4.2, valued at $133.5k
Converted 87,851 shares @ $4.2, valued at $369k
Converted 27,378 shares @ $4.2, valued at $115k
Converted 14,811 shares @ $6.75, valued at $100k
Converted options to buy @ $0
Converted 103,682 options to buy @ $0
Granted 24,602 options to buy @ $0
Granted 71,428 options to buy @ $0
Granted 23,809 options to buy @ $0
Granted 47,935 options to buy @ $5.25, valued at $251.7k
03/07/2023 4 Meghji Mohsin Y (Director) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Converted 40,907 shares @ $3.67, valued at $150.1k
Converted 286,349 options to buy @ $0
12/05/2022 4 Zannes Timothy P (Secretary, EVP, Gen. Counsel) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 3,619 shares @ $0
12/05/2022 4 KNIGHT PETER S (Director) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Bought 8,163 shares @ $0
Bought 8,163 options to buy @ $0
12/02/2022 4 Anderson Robert A. (Director) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Bought 4,081 shares @ $0
Bought 4,081 options to buy @ $0
12/02/2022 4 DIAMOND STUART (Director) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Bought 4,081 shares @ $0
Bought 4,081 options to buy @ $0
11/29/2022 4 Edwards James Michael (CFO) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Bought 2,448 shares @ $0
Converted 2,243 shares @ $4.2, valued at $9.4k
Granted 3,619 shares @ $0
Bought 2,448 options to buy @ $0
Converted options to buy @ $0
Granted 1,903 options to buy @ $0
Granted 761 options to buy @ $5.25, valued at $4k
11/22/2022 4 Rebel Vivienne I (EVP, Chief Sci. & Med. Officer) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Granted 7,239 shares @ $0
11/22/2022 4 Zannes Maria (President, CEO) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Bought 16,326 shares @ $0
Converted 23,672 shares @ $4.2, valued at $99.4k
Granted 18,099 shares @ $0
Bought 16,326 options to buy @ $0
Converted options to buy @ $0
Granted 23,571 options to buy @ $0
11/08/2022 4 GIRGENTI STEVEN (Executive Chairman) has filed a Form 4 on bioAffinity Technologies, Inc.
Txns: Converted 7,657 shares @ $4.2, valued at $32.2k
Converted 156,602 shares @ $4.2, valued at $657.7k
Converted 7,657 shares @ $4.2, valued at $32.2k
Converted 59,141 shares @ $4.2, valued at $248.4k
Converted 58,797 shares @ $4.2, valued at $246.9k
Converted 27,378 shares @ $4.2, valued at $115k
Converted 4,912 shares @ $4.2, valued at $20.6k
Converted 2,694 shares @ $4.2, valued at $11.3k
Converted 13,326 shares @ $4.2, valued at $56k
Converted 10,632 shares @ $4.2, valued at $44.7k
Converted 39,275 shares @ $4.2, valued at $165k
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy